Hypoallergenic casein hydrolysate for peptide-based oral immunotherapy in cow's milk allergy - 04/07/18
This study was supported in part by the Research and Development Program for New Bio-industry Initiatives of the Bio-oriented Technology Research Advancement Institution (BRAIN), Japan (grant no. 2005-2009). BRAIN made no substantial contribution to the study, except for the financial support. |
|
Disclosure of potential conflict of interest: H. M. Ueno, T. Kato, and T. Nakano are employees of Bean Stalk Snow Co Ltd. The rest of the authors declare that they have no relevant conflicts of interest. |
Vol 142 - N° 1
P. 330-333 - juillet 2018 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?